The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a study of patients with hip fractures.
The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a study of patients with hip fractures.